Medicine
COVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer Treatments
Participation rates were already low, but the pandemic threatens to drive them even lower
Stories by Pat Basu
Pat Basu, M.D, MBA, is president of Cancer Treatment Centers of America (CTCA).
